Answer
Galafold (migalastat hydrochloride) is indicated for long-term treatment of adults and adolescents aged 12 years and older with confirmed Fabry disease and an amenable mutation.
Sources for this answer
- Galafold 123 mg hard capsulesAmicus Therapeutics UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated
Sources checked